Sorrento Therapeutics competitors and similar companiesClear all

Sorrento Therapeutics's competitors and similar companies include Celyad, Alnylam Pharmaceuticals, Luna Innovations and Kuros Biosciences.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Luna Innovations
Luna Innovations
Luna Innovations is a company that specializes in optical technologies, fiber optic tests, measurement, and control products.
Kuros Biosciences
Kuros Biosciences
Kuros Biosciences engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases internationally.
Founding Date
Founding Date
2006
Founding Date
2007
Founding Date
2002
Founding Date
1990
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
San Diego, US
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Roanoke, US HQ
Köln, DE
Farnborough, GB
Portishead, GB
Winfrith Newburgh, GB
Ann Arbor, US
Atlanta, US
see more
Locations
Schlieren, CH HQ
Bilthoven, NL
Burlington, US
Employees
Employees
31019% decrease
Employees
95
Employees
1,32324% increase
Employees
3852% decrease
Employees
58
Valuation ($)
Valuation ($)
558.8 m
Valuation ($)
30.8 m
Valuation ($)
27.1 b
Valuation ($)
282.6 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
16 k
Twitter followers
644
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
9.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
401759
Alexa Website Rank
460272
Alexa Website Rank
460935
Alexa Website Rank
437585
Alexa Website Rank
699412
Employee Rating
Employee Rating
3.4
Employee Rating
3.5
Employee Rating
4.2
Employee Rating
3.2
Employee Rating
5

Financial

Revenue (est.)
Revenue (est.)
$52.9m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$844.3m (FY, 2021)
Revenue (est.)
$87.5m (FY, 2021)
Revenue (est.)
CHF13.8m (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$115m (FY, 2021)
Cost of goods
$36m (FY, 2021)
Cost of goods
CHF1.4m (FY, 2021)
Gross profit
Gross profit
N/A
Gross profit
€5.8m (FY, 2021)
Gross profit
N/A
Gross profit
$51.6m (FY, 2021)
Gross profit
CHF12.7m (FY, 2021)
Net income
Net income
($429.1m) (FY, 2021)
Net income
(€26.5m) (FY, 2021)
Net income
($852.8m) (FY, 2021)
Net income
$1.4m (FY, 2021)
Net income
(CHF7.5m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 42.6m
Total funding raised
N/A
Total funding raised
$ 1.5b
Total funding raised
$ 13.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Celyad
HQ
Mont-Saint-Guibert, BE
Employees
95

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Luna Innovations
HQ
Roanoke, US
Employees
385↓ 2% decrease

Luna Innovations is a company that specializes in optical technologies, fiber optic tests, measurement, and control products.

View company
Kuros Biosciences
HQ
Schlieren, CH
Employees
58

Kuros Biosciences engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases internationally.

View company